ASCO Guideline Update on VTE Prophylaxis and Treatment in Patients with Cancer
The American Society of Clinical Oncology (ASCO) has been developing guidelines on cancer-associated thrombosis (CAT)...
ARCHIVE
Occult cancer and unprovoked venous thromboembolism: What’s their relationship?
Occult cancers are generally advanced or metastatic tumors with unknown primary origin. In some cases, they are...
Immune checkpoint inhibitors and cancer-associated thrombosis: an overview
Immune checkpoint inhibitors (ICIs) are a type of immunotherapy that revolutionized cancer treatment and, in recent...
RECORDING AVAILABLE: Challenges in the management of fragile CAT patients (older patient population & palliative care)
You can now watch the recording of “Challenges in the management of fragile CAT patients (older patient...
Risk factors for recurrence and major bleeding in cancer-associated thrombosis: a sub-analysis of the Caravaggio study
Patients with cancer have a high risk of recurrent venous thromboembolism (VTE) and major bleeding, which greatly...
Empowering Cancer Patients: Understanding and Preventing Thrombosis
Cancer patients face numerous challenges on their journey, and one often overlooked concern is the increased risk of...
Abstract submission deadline for ESMO Breast Cancer Congress
Time is almost up to submit your abstract for the next European Society for Medical Oncology (ESMO) Breast Cancer...
Abstract submission now open for ESMO 2023
Time to submit your abstract for the next European Society for Medical Oncology (ESMO) Congress. The ESMO...
How does clinical thrombosis presentation affect illness perception in patients with cancer-associated thrombosis?
Although thrombosis is the second cause of death in patients with cancer, after cancer itself, most of these patients...
31th Congress of the International Society on Thrombosis and Haemostasis
31th Congress of the International Society on Thrombosis and Haemostasis (ISTH) June 24-28, 2023. Montréal, Quebec,...